|
|
|
Insider
Information: |
Culley Brian M |
Relationship: |
|
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
214,342 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$288,719 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
214,342 |
|
|
Total
Value |
$288,719 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Savara Inc |
SVRA |
CEO and Director, Dire... |
2012-03-14 |
34,500 |
2010-05-27 |
0 |
Premium* |
|
Inksure Technologies Inc |
INKS |
Chief Executive Officer |
2017-10-23 |
25,000 |
2017-10-23 |
0 |
Premium* |
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
|
2024-05-24 |
154,842 |
2019-01-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INKS |
Inksure Technologies Inc |
Chief Executive Officer |
|
2017-10-23 |
4 |
B |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
2.66 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2019-01-01 |
4 |
D |
$0.91 |
$37,323 |
D/D |
(40,880) |
59,120 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2019-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2019-08-13 |
4 |
B |
$1.01 |
$10,100 |
D/D |
10,000 |
84,531 |
2.81 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2019-09-17 |
4 |
D |
$1.00 |
$21,371 |
D/D |
(21,371) |
124,960 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2019-09-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
61,800 |
146,331 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2019-09-30 |
4 |
D |
$0.98 |
$5,236 |
D/D |
(5,343) |
135,067 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2019-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,450 |
140,410 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2019-12-31 |
4 |
D |
$0.89 |
$4,755 |
D/D |
(5,343) |
145,174 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2019-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,450 |
150,517 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2020-03-31 |
4 |
D |
$0.83 |
$4,425 |
D/D |
(5,343) |
155,281 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2020-03-31 |
4 |
OE |
$0.83 |
$12,794 |
D/D |
15,450 |
160,624 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2020-06-30 |
4 |
D |
$0.87 |
$4,648 |
D/D |
(5,343) |
165,388 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2020-06-30 |
4 |
OE |
$0.87 |
$13,442 |
D/D |
15,450 |
170,731 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2020-09-30 |
4 |
OE |
$0.94 |
$14,470 |
D/D |
15,450 |
180,838 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2020-09-30 |
4 |
D |
$0.94 |
$5,004 |
D/D |
(5,343) |
175,495 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2020-12-31 |
4 |
D |
$1.76 |
$9,404 |
D/D |
(5,343) |
185,602 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2020-12-31 |
4 |
OE |
$1.76 |
$27,192 |
D/D |
15,450 |
190,945 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2021-03-31 |
4 |
D |
$2.35 |
$12,556 |
D/D |
(5,343) |
195,709 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2021-03-31 |
4 |
OE |
$2.35 |
$36,308 |
D/D |
15,450 |
201,052 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2021-06-28 |
4 |
AS |
$2.87 |
$1,291,500 |
D/D |
(450,000) |
45,709 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2021-06-28 |
4 |
OE |
$0.69 |
$207,570 |
D/D |
300,000 |
495,709 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2021-06-30 |
4 |
D |
$2.85 |
$15,228 |
D/D |
(5,343) |
55,816 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2021-06-30 |
4 |
OE |
$2.85 |
$44,033 |
D/D |
15,450 |
61,159 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
President and CEO |
|
2021-09-30 |
4 |
D |
$2.52 |
$13,464 |
D/D |
(5,343) |
65,923 |
0 |
- |
|
42 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|